Lilly Asia Ventures invests in MabSpace Biosciences
MabSpace Biosciences Co. Ltd. said Wednesday that it completed a $15 million Series A financing round. Lilly Asia Ventures was the sole investor of the Series A. Suzhou, China-based MabSpace is focused on the discovery and development of antibody-based therapeutics.
28 October 2015•2 mins read
